CASPOFUNGIN

SynDRA canonical compound SYN0025821 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	bacterial cell wall synthesis inhibitor \| fungal 1,3-beta-D-glucan synthase inhibitor
Indication	aspergillosis \| candidemia \| esophageal candidiasis \| fungal infection \| peritonitis
Disease area	infectious disease

All known targets

caspofungin acetate
caspofungin diacetate
cancidas
MK-0991
Caspofungine
Caspofungina
L-743,872
L-743872
CASPO
Cancidas
Capsofungin
Caspofungin [INN]
M991
Cancidas (TM)
Cancidas (TN)
Caspofungin (INN)
[1(R)-hydroxyethyl]-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0(9,13)]heptacosane-2,5,8,14,17,23-hexaone diacetate
Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-(9CI)
(4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide
(4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide
1-[(4R,5S)-5-[(2-aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0
L 743,872
F0XDI6ZL63
caspofungine
caspofunginum
CHEBI:474180
RefChem:56792
J02AX04
DTXCID701508490
L743872
L743,872
Caspofungin [INN:BAN]
CASPOFUNGIN [MI]
CASPOFUNGIN [HSDB]
UNII-F0XDI6ZL63
(10R,12S)-caspofungin
CASPOFUNGIN [VANDF]
CASPOFUNGIN [WHO-DD]